ARA290 Peptide: The Next Frontier in Neuroprotection and Tissue Repair
Are you looking to buy ARA290 for your next research project? ARA290 (also known as Cibinetide) is a groundbreaking, non-erythropoietic peptide derived from the structure of Erythropoietin (EPO).
Unlike standard EPO, ARA290 selectively targets the Innate Repair Receptor (IRR), offering potent anti-inflammatory and tissue-protective benefits without stimulating red blood cell production.
What is ARA290?
ARA290 is an 11-amino acid linear peptide (Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-OH) modeled after the B-helix of the EPO molecule.
It was specifically engineered to activate the body’s endogenous repair systems while avoiding the hematopoietic side effects—such as increased blood viscosity—associated with traditional EPO.
Buy ARA290 Key Benefits and Research Findings
When you buy ARA290, you are investing in a peptide with a diverse range of studied applications:
- Neuropathic Pain Relief: Clinical trials have shown that ARA290 significantly reduces symptoms of Small Fiber Neuropathy (SFN) related to sarcoidosis and Type 2 diabetes. It works by suppressing spinal microglia activation and reducing central inflammation.
- Nerve Fiber Regeneration: Research indicates that ARA290 may increase corneal nerve fiber density and stimulate the regrowth of damaged small nerve fibers.
- Metabolic Support: Studies in diabetic patients have observed improvements in HbA1c levels, lipid profiles (including increased HDL and reduced triglycerides), and overall glucose control.
- Cardiovascular Protection: Preclinical data suggest ARA290 can reduce age-associated cardiac inflammation, mitigate structural remodeling of the heart, and improve survival following myocardial infarction.
- Enhanced Quality of Life: Trial participants reported significant improvements in vitality (energy levels) and physical functioning.
Mechanism of Action
ARA290 functions by binding to the Innate Repair Receptor (IRR), a heterocomplex of the EPO receptor and the β-common receptor (CD131). Upon activation, the IRR initiates a cascade that:
- Inhibits Pro-inflammatory Cytokines: It specifically targets pathways like NF-κB and TNF-α to “silence” chronic inflammation.
- Blocks TRPV1 Channels: It acts as an antagonist for TRPV1 channels, which are responsible for many types of pain sensation.
- Promotes Cell Survival: It activates anti-apoptotic signals to protect tissues from stress and injury.
Dosing and Administration for Research
For those looking to buy ARA290 for laboratory or clinical research, typical administration protocols involve:
- Form: Lyophilized powder reconstituted with bacteriostatic water.
- Standard Research Dose: 4 mg administered via daily subcutaneous (SC) injection for a 28-day cycle.
- Bioavailability: Subcutaneous administration achieves peak plasma concentrations within 12–15 minutes, with a terminal half-life of roughly 20 minutes.
Storage and Stability
- Lyophilized: Stable for up to 2 years in a refrigerator or 3 years in a freezer (keep away from light).
- Reconstituted: Once mixed, store in the refrigerator and use within 6 weeks to maintain maximum potency.
Why Buy ARA290 from Us?
Our ARA290 is sourced with the highest purity standards to ensure reliable results in every vial. We provide:
- Fast, Discrete Shipping
- Secure Checkout
- Verified Lab Analysis



Reviews
There are no reviews yet.